Irreversible inhibition of human cytomegalovirus replication by topoisomerase II inhibitor, etoposide: A new strategy for the treatment of human cytomegalovirus infection-Reference-Cited by-同舟云学术

Irreversible inhibition of human cytomegalovirus replication by topoisomerase II inhibitor, etoposide: A new strategy for the treatment of human cytomegalovirus infection

Published:1992-01 Issue:1 Volume:17 Page:17-32
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Huang Eng-Shang,Benson John D.,Huong Shu-mei,Wilson Belinda,van der Horst Charles

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference31 articles.

1. Two specific topoisomerase II inhibitors prevent replication of human cytomegalovirus DNA: an implied role in replication of the viral genome;Benson;J. Virol.,1988

2. Human cytomegalovirus induces expression of cellular topoisomerase II;Benson;J. Virol.,1990

3. Differential affinities of 5-(2-halovinyl)-2′-deoxyluridine for deoxythymidine kinase of various origin;Cheng;Mol. Pharmacol.,1981

4. Biochemical aspects of the selective anti-herpes activity of nucleoside analogues;De Clercq;Biochem. Pharmacol.,1984

5. Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin-sensitive and -resistant P388 leukemia cell lines;Deffie;Cancer Res.,1989

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Topoisomerase II β Gene Specific siRNA Delivery by Nanoparticles Prepared with c-ter Apotransferrin and its Effect on HIV-1 Replication;Molecular Biotechnology;2021-05-16

2. Development of a high-content screen for the identification of inhibitors directed against the early steps of the cytomegalovirus infectious cycle;Antiviral Research;2015-01

3. Basic and Clinical Aspects of Human Cytomegalovirus Infection;The Spectrum of Neuro-AIDS Disorders;2014-04-09

4. Involvement of human topoisomerase II isoforms in HIV-1 reverse transcription;Archives of Biochemistry and Biophysics;2013-04

5. The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication;Cellular and Molecular Life Sciences;2010-08-30